EXAGEN INC.·4

Mar 26, 7:17 PM ET

Zack Debra 4

4 · EXAGEN INC. · Filed Mar 26, 2020

Insider Transaction Report

Form 4
Period: 2020-03-24
Zack Debra
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-03-24+100,000100,000 total
    Exercise: $13.44Exp: 2030-03-23Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option is exercisable as it vests. 25% of the shares subject to the option vest on March 24, 2021, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION